{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:43:31Z","timestamp":1793069011092,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,6]],"date-time":"2027-09-06T00:00:00Z","timestamp":1820188800000},"content-version":"am","delay-in-days":340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["R01HL167828"],"award-info":[{"award-number":["R01HL167828"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["R01AI146160"],"award-info":[{"award-number":["R01AI146160"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ijpharm.2026.127361","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T23:13:56Z","timestamp":1788045236000},"page":"127361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Impact of hydrolyzed gelatin and hydroxypropyl-\u03b2-cyclodextrin as polymeric excipients on physical stability and injectability of high-concentration protein suspensions"],"prefix":"10.1016","volume":"703","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5070-8920","authenticated-orcid":false,"given":"Chanakya D.","family":"Patil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1583-5767","authenticated-orcid":false,"given":"Yijing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinnari Santosh","family":"Arte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachana","family":"Sapkota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza Babakhani","family":"Galangashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlos P.","family":"Vlachos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8154-6360","authenticated-orcid":false,"given":"Eric J.","family":"Munson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"(Tony) Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"(Lily) Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijpharm.2026.127361_b0005","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejpb.2014.01.009","article-title":"Rheological characterization and injection forces of concentrated protein formulations: an alternative predictive model for non-Newtonian solutions","volume":"87","author":"Allmendinger","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"7","key":"10.1016\/j.ijpharm.2026.127361_b0010","first-page":"2321","article-title":"A review on pharmaceutical suspension and its advancement","volume":"2022","author":"Arora","year":"2022","journal-title":"Ann. Clin. Case Rep."},{"key":"10.1016\/j.ijpharm.2026.127361_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125636","article-title":"Understanding the impact of L-leucine on physical stability and aerosolization of spray-dried protein powder formulations containing trehalose","volume":"677","author":"Arte","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2026.127361_b0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2147\/DDDT.S287323","article-title":"\u201cSubcutaneous delivery of high-dose\/volume biologics: current status and prospect for future advancements","author":"Badkar","year":"2021","journal-title":"Drug Design, Develop. Ther."},{"key":"10.1016\/j.ijpharm.2026.127361_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119029","article-title":"Excipients in freeze-dried biopharmaceuticals: contributions toward formulation stability and lyophilisation cycle optimisation","volume":"576","author":"Bjelosevic","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.ijpharm.2026.127361_b0030","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1002\/jps.23324","article-title":"Investigating high-concentration monoclonal antibody powder suspension in nonaqueous suspension vehicles for subcutaneous injection","volume":"101","author":"Bowen","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2026.127361_b0035","unstructured":"Brown, P., Charles, L.F., Jr, Coffman, C.S., Dadon, D.B., Ivey, J., Liu, L., Sudrik, C., 2023. Particle formation and morphology, Google Patents."},{"issue":"1","key":"10.1016\/j.ijpharm.2026.127361_b0040","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1208\/s12249-013-0036-0","article-title":"The effect of moisture on the flowability of pharmaceutical excipients","volume":"15","author":"Crouter","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2026.127361_b0045","article-title":"Non-aqueous high concentration reduced viscosity suspension formulations of antibodies","author":"Dai","year":"2015","journal-title":"Google Patents."},{"issue":"3","key":"10.1016\/j.ijpharm.2026.127361_b0050","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/molecules30030482","article-title":"The pharmaceutical industry in 2024: an analysis of the FDA drug approvals from the perspective of molecules","volume":"30","author":"de la Torre","year":"2025","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.ijpharm.2026.127361_b0055","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1080\/17425247.2025.2477656","article-title":"Performance characterization of spring-actuated prefilled pen devices for lebrikizumab and dupilumab","volume":"22","author":"Derakhshandeh","year":"2025","journal-title":"Expert Opin. Drug Deliv."},{"issue":"8","key":"10.1016\/j.ijpharm.2026.127361_b0060","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1080\/03007995.2020.1783219","article-title":"Performance characterization of spring actuated autoinjector devices for Emgality and Aimovig","volume":"36","author":"Dou","year":"2020","journal-title":"Curr. Med. Res. Opin."},{"issue":"9","key":"10.1016\/j.ijpharm.2026.127361_b0065","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/jps.20418","article-title":"Particle size and density in spray drying-effects of carbohydrate properties","volume":"94","author":"Elversson","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2026.127361_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cis.2011.12.005","article-title":"Shear rheology of hard-sphere, dispersed, and aggregated suspensions, and filler-matrix composites","volume":"171\u2013172","author":"Genovese","year":"2012","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2026.127361_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.02.069","article-title":"An industry perspective on hyaluronidase co-formulated biopharmaceutics","volume":"381","author":"Guo","year":"2025","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.ijpharm.2026.127361_b0080","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1021\/acs.molpharmaceut.2c00039","article-title":"Spray-dried monoclonal antibody suspension for high-concentration and low-viscosity subcutaneous injection","volume":"19","author":"Huang","year":"2022","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.ijpharm.2026.127361_b0085","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3390\/pharmaceutics17020199","article-title":"Impact of co-spray drying with leucine or trileucine on aerosol performance, in vitro dissolution, and cellular uptake of colistin powder formulations for inhalation","volume":"17","author":"Huang","year":"2025","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.ijpharm.2026.127361_b0090","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3390\/pharmaceutics18040450","article-title":"Recent advances in particle design for high-concentration protein suspension injectables","volume":"18","author":"Huang","year":"2026","journal-title":"Pharmaceutics"},{"issue":"812","key":"10.1016\/j.ijpharm.2026.127361_b0095","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adv6427","article-title":"Ultrahigh-concentration biologic therapeutics enabled by spray drying with a glassy surfactant excipient","volume":"17","author":"Jons","year":"2025","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.ijpharm.2026.127361_b0100","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01513064","article-title":"An empirical-equation of the relative viscosity of polymer melts filled with various inorganic fillers","volume":"20","author":"Kitano","year":"1981","journal-title":"Rheol. Acta"},{"key":"10.1016\/j.ijpharm.2026.127361_b0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.powtec.2014.05.044","article-title":"Experimental study of the viscosity of suspensions: effect of solid fraction, particle size and suspending liquid","volume":"266","author":"Konijn","year":"2014","journal-title":"Powder Technol."},{"issue":"5","key":"10.1016\/j.ijpharm.2026.127361_b0110","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0032-5910(71)80047-5","article-title":"Studies of surfactants in nonaqueous powder suspensions","volume":"4","author":"Kracke","year":"1971","journal-title":"Powder Technol."},{"issue":"12","key":"10.1016\/j.ijpharm.2026.127361_b0115","doi-asserted-by":"crossref","first-page":"6484","DOI":"10.1021\/acs.molpharmaceut.4c01174","article-title":"\u201cThe more, the better?\u201d: The impact of sugar-to-protein molar ratio in freeze-dried monoclonal antibody formulations on protein stability","volume":"21","author":"Lo Presti","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2026.127361_b0120","article-title":"High-concentration biologic formulations: challenges, strategies, and emerging technologies for subcutaneous delivery","volume":"115178","author":"Ma","year":"2026","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.ijpharm.2026.127361_b0125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/10837459709031441","article-title":"The effect of operating and formulation variables on the morphology of spray-dried protein particles","volume":"2","author":"Maa","year":"1997","journal-title":"Pharm. Dev. Technol."},{"issue":"5","key":"10.1016\/j.ijpharm.2026.127361_b0130","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1023\/A:1011983322594","article-title":"Effect of spray drying and subsequent processing conditions on residual moisture content and physical\/biochemical stability of protein inhalation powders","volume":"15","author":"Maa","year":"1998","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ijpharm.2026.127361_b0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.xphs.2022.06.016","article-title":"Drug product characterization of high concentration non-aqueous protein powder suspensions","volume":"112","author":"Marschall","year":"2023","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2026.127361_b0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejpb.2021.01.014","article-title":"Powder suspensions in non-aqueous vehicles for delivery of therapeutic proteins","volume":"161","author":"Marschall","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"8","key":"10.1016\/j.ijpharm.2026.127361_b0145","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.3390\/biomedicines13081962","article-title":"Monoclonal antibodies (mAbs) and proteins: the biologic drugs approved by the food and drug administration (FDA) in 2024","volume":"13","author":"Martins","year":"2025","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/j.ijpharm.2026.127361_b0150","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.xphs.2016.05.029","article-title":"Subcutaneous injection volume of biopharmaceuticals-pushing the boundaries","volume":"105","author":"Mathaes","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2026.127361_b0155","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejpb.2017.01.024","article-title":"How sugars protect proteins in the solid state and during drying (review): mechanisms of stabilization in relation to stress conditions","volume":"114","author":"Mensink","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.ijpharm.2026.127361_b0160","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s12551-025-01346-2","article-title":"Developing high-concentration monoclonal antibody formulations for subcutaneous administration to improve patient treatment","volume":"17","author":"Mijangos","year":"2025","journal-title":"Biophys. Rev."},{"issue":"2","key":"10.1016\/j.ijpharm.2026.127361_b0165","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1021\/la9023426","article-title":"Low viscosity highly concentrated injectable nonaqueous suspensions of lysozyme microparticles","volume":"26","author":"Miller","year":"2010","journal-title":"Langmuir"},{"key":"10.1016\/j.ijpharm.2026.127361_b0170","unstructured":"Newey-Keane, L., Carrington, S., 2016. Controlling the stability of medicinal suspensions. Am. Pharm. Rev."},{"key":"10.1016\/j.ijpharm.2026.127361_b0175","article-title":"Stabilization of spray-dried monoclonal antibody formulations with polymeric excipients","volume":"104360","author":"Patil","year":"2026","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ijpharm.2026.127361_b0180","first-page":"1","article-title":"Polymers as stabilizing excipients for spray-dried protein formulations","volume":"43","author":"Patil","year":"2025","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2026.127361_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124974","article-title":"Effects of buffers on spray-freeze-dried\/lyophilized high concentration protein formulations","volume":"668","author":"Patil","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijpharm.2026.127361_b0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0378-5173(94)00186-9","article-title":"Biological characterization of rbSt oil suspensions","volume":"113","author":"Pena","year":"1995","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ijpharm.2026.127361_b0195","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.xphs.2020.12.016","article-title":"Product-specific impact of viscosity modulating formulation excipients during ultra-high concentration biotherapeutics drug product development","volume":"110","author":"Rodrigues","year":"2021","journal-title":"J. Pharm. Sci."},{"issue":"11","key":"10.1016\/j.ijpharm.2026.127361_b0200","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1039\/c0sm01312a","article-title":"Rheology of globular proteins: apparent yield stress, high shear rate viscosity and interfacial viscoelasticity of bovine serum albumin solutions","volume":"7","author":"Sharma","year":"2011","journal-title":"Soft Matter"},{"issue":"10","key":"10.1016\/j.ijpharm.2026.127361_b0205","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1016\/j.xphs.2022.05.011","article-title":"Viscosity reduction and stability enhancement of monoclonal antibody formulations using derivatives of amino acids","volume":"111","author":"Srivastava","year":"2022","journal-title":"J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.ijpharm.2026.127361_b0210","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1021\/acs.molpharmaceut.5c00639","article-title":"Combination of hydroxypropyl-beta-cyclodextrin and trehalose for improved stability of spray-dried monoclonal antibodies","volume":"22","author":"Tam","year":"2025","journal-title":"Mol. Pharm."},{"issue":"A1","key":"10.1016\/j.ijpharm.2026.127361_b0215","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1205\/026387699525846","article-title":"Spray dried products - characterization of particle morphology","volume":"77","author":"Walton","year":"1999","journal-title":"Chem. Eng. Res. Desig."},{"issue":"12","key":"10.1016\/j.ijpharm.2026.127361_b0220","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1021\/acs.molpharmaceut.5b00643","article-title":"Viscosity-lowering effect of amino acids and salts on highly concentrated solutions of two IgG1 monoclonal antibodies","volume":"12","author":"Wang","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2026.127361_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2025.114901","article-title":"Improving prefilled syringe injectability: influences of critical component attributes and human factors","volume":"217","author":"Wang","year":"2025","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2026.127361_b0230","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijpharm.2018.11.012","article-title":"Injectability as a function of viscosity and dosing materials for subcutaneous administration","volume":"554","author":"Watt","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijpharm.2026.127361_b0235","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/cts.13109","article-title":"Clinical evaluation of large volume subcutaneous injection tissue effects, pain, and acceptability in healthy adults","volume":"15","author":"Woodley","year":"2022","journal-title":"Clin. Transl. Sci."},{"issue":"3","key":"10.1016\/j.ijpharm.2026.127361_b0240","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.xphs.2025.01.028","article-title":"Developing ultra-high concentration formulations of human immune globulins for subcutaneous injectables","volume":"114","author":"Yadav","year":"2025","journal-title":"J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.ijpharm.2026.127361_b0245","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s11095-011-0424-7","article-title":"Viscosity analysis of high concentration bovine serum albumin aqueous solutions","volume":"28","author":"Yadav","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2026.127361_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120535","article-title":"Protein-protein interactions at high concentrations: effects of ArgHCl and NaCl on the stability, viscosity and aggregation mechanisms of protein solution","volume":"601","author":"Ye","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ijpharm.2026.127361_b0255","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3390\/molecules27030999","article-title":"Influence of low molecular weight salts on the viscosity of aqueous-buffer bovine serum albumin solutions","volume":"27","author":"Zdovc","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ijpharm.2026.127361_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2026.115854","article-title":"Protein stability and viscosity in molecularly crowded high-concentration biologics","volume":"233","author":"Zheng","year":"2026","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2026.127361_b0265","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jcis.2020.06.105","article-title":"Control of viscosity in biopharmaceutical protein formulations","volume":"580","author":"Zidar","year":"2020","journal-title":"J. Colloid Interface Sci."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517326008094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517326008094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:20:54Z","timestamp":1789834854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517326008094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":53,"alternative-id":["S0378517326008094"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2026.127361","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of hydrolyzed gelatin and hydroxypropyl-\u03b2-cyclodextrin as polymeric excipients on physical stability and injectability of high-concentration protein suspensions","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2026.127361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"127361"}}